Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26Rectal Neoplasms 19Colonic Neoplasms 18Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 11Stomach Neoplasms 9Burkitt Lymphoma 7Pancreatic Neoplasms 5Leukemia, Biphenotypic, Acute 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Dendritic Cell Sarcoma, Interdigitating 3Lymphoma, Mantle-Cell 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Sarcoma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neutropenia 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Hydatidiform Mole 1

Interventions

PEGPH20 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Metastatic Pancreatic Adenocarcinoma × Leucovorin × Clear all
NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡